Hill-Rom Holdings Revenue 2006-2019 | HRC

Hill-Rom Holdings annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Hill-Rom Holdings revenue for the quarter ending June 30, 2019 was $0.727B, a 2.57% increase year-over-year.
  • Hill-Rom Holdings revenue for the twelve months ending June 30, 2019 was $2.884B, a 2% increase year-over-year.
  • Hill-Rom Holdings annual revenue for 2018 was $2.848B, a 3.8% increase from 2017.
  • Hill-Rom Holdings annual revenue for 2017 was $2.744B, a 3.33% increase from 2016.
  • Hill-Rom Holdings annual revenue for 2016 was $2.655B, a 33.55% increase from 2015.
Hill-Rom Holdings Annual Revenue
(Millions of US $)
2018 $2,848
2017 $2,744
2016 $2,655
2015 $1,988
2014 $1,686
2013 $1,716
2012 $1,634
2011 $1,592
2010 $1,470
2009 $1,387
2008 $1,508
2007 $1,357
2006 $1,288
2005 $1,938
Hill-Rom Holdings Quarterly Revenue
(Millions of US $)
Q3 2019 $727
Q2 2019 $714
Q1 2018 $684
Q4 2018 $759
Q3 2018 $709
Q2 2018 $711
Q1 2017 $670
Q4 2017 $738
Q3 2017 $689
Q2 2017 $679
Q1 2016 $637
Q4 2016 $706
Q3 2016 $655
Q2 2016 $633
Q1 2015 $661
Q4 2015 $574
Q3 2015 $475
Q2 2015 $475
Q1 2014 $465
Q4 2014 $480
Q3 2014 $398
Q2 2014 $415
Q1 2013 $393
Q4 2013 $438
Q3 2013 $424
Q2 2013 $426
Q1 2012 $428
Q4 2012 $432
Q3 2012 $407
Q2 2012 $415
Q1 2011 $381
Q4 2011 $431
Q3 2011 $385
Q2 2011 $402
Q1 2010 $374
Q4 2010 $397
Q3 2010 $361
Q2 2010 $357
Q1 2009 $355
Q4 2009 $363
Q3 2009 $335
Q2 2009 $337
Q1 2008 $352
Q4 2008 $424
Q3 2008 $367
Q2 2008 $375
Q1 2007 $341
Q4 2007 $530
Q3 2007 $329
Q2 2007 $335
Q1 2006 $483
Q4 2006 $521
Q3 2006 $469
Q2 2006 $496
Q1 2005 $478
Q4 2005 $497
Q3 2005 $466
Q2 2005 $501
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.817B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.323B 26.71
Medtronic (MDT) Ireland $145.061B 20.36
Stryker (SYK) United States $80.552B 27.85
Boston Scientific (BSX) United States $53.588B 25.99
Baxter (BAX) United States $44.924B 27.24
EssilorLuxottica Societe Anonyme (ESLOY) France $32.865B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.253B 18.08
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.356B 0.00
Terumo (TRUMY) Japan $24.335B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.897B 0.00
ResMed (RMD) United States $18.864B 35.95
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.229B 54.83
Insulet (PODD) United States $9.266B 549.07
Perrigo (PRGO) Ireland $7.333B 13.51
Canopy Growth (CGC) Canada $7.030B 0.00
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.648B 0.00
NuVasive (NUVA) United States $3.463B 27.61
Neogen (NEOG) United States $3.393B 56.77
ICU Medical (ICUI) United States $3.219B 20.88
Quidel (QDEL) United States $2.561B 25.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.550B 0.00
Agios Pharmaceuticals (AGIO) United States $1.943B 0.00
National Vision Holdings (EYE) United States $1.805B 38.97
Cardiovascular Systems (CSII) United States $1.730B 0.00
Aphria (APHA) $1.197B 0.00
VAREX IMAGING (VREX) United States $1.103B 25.42
AtriCure (ATRC) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.853B 13.88
Eagle Pharmaceuticals (EGRX) United States $0.843B 21.50
Omeros (OMER) United States $0.782B 0.00
NanoString Technologies (NSTG) United States $0.760B 0.00
Lantheus Holdings (LNTH) United States $0.732B 19.25
LeMaitre Vascular (LMAT) United States $0.696B 41.24
PetIQ (PETQ) United States $0.676B 15.98
Cerus (CERS) United States $0.627B 0.00
Surmodics (SRDX) United States $0.605B 114.95
MacroGenics (MGNX) United States $0.538B 0.00
Quanterix (QTRX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.21
TG Therapeutics (TGTX) United States $0.518B 0.00
Owens & Minor (OMI) United States $0.450B 13.47
Meridian Bioscience (VIVO) United States $0.428B 13.37
Utah Medical Products (UTMD) United States $0.356B 26.11
Zynex (ZYXI) United States $0.340B 36.14
BioLife Solutions (BLFS) United States $0.332B 102.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.326B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.229B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.146B 0.00
Female Health (VERU) United States $0.140B 0.00
Fonar (FONR) United States $0.130B 9.14
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.085B 20.00
Nephros (NEPH) United States $0.083B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00